Cargando…
The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes
The placenta is the site of connection between maternal and fetal circulation, and the liaison is established early in pregnancy. A large variety of pregnancy complications such as preterm birth, fetal growth restriction, or pregnancy loss have placental expression and can be accompanied in some cas...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775717/ https://www.ncbi.nlm.nih.gov/pubmed/35052331 http://dx.doi.org/10.3390/healthcare10010168 |
_version_ | 1784636654825242624 |
---|---|
author | Bouariu, Alexandra Gică, Nicolae Ciobanu, Anca Marina Scutelnicu, Ana Maria Popescu, Mihaela Roxana Panaitescu, Anca Maria |
author_facet | Bouariu, Alexandra Gică, Nicolae Ciobanu, Anca Marina Scutelnicu, Ana Maria Popescu, Mihaela Roxana Panaitescu, Anca Maria |
author_sort | Bouariu, Alexandra |
collection | PubMed |
description | The placenta is the site of connection between maternal and fetal circulation, and the liaison is established early in pregnancy. A large variety of pregnancy complications such as preterm birth, fetal growth restriction, or pregnancy loss have placental expression and can be accompanied in some cases of acute or chronic identifiable placental inflamatory lesions. Chronic placental inflammatory (CPI) lesions include chronic villitis of unknow etiology (CVUE), chronic intervillositis of unknown etiology, CIUE (also described as chronic histiocytic intervillositis, CHI), and chronic deciduits. Hydroxychloroquine (HCQ) has been prescribed with good results during pregnancy to prevent adverse perinatal outcomes in maternal autoimmune conditions. Its success has paved the way to its use in CPI as CIUE/CHI; however, to date, there are no prospective, informatively designed, controlled studies on its value in these setting. This review aims to explore the potential role of HCQ in CPI of unknown etiology. Ideally, properly designed, probably multicentric studies should be undertaken to fully understand HCQ’s role for prevention of adverse pregnancy outcomes after a chronic placental inflammation. |
format | Online Article Text |
id | pubmed-8775717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87757172022-01-21 The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes Bouariu, Alexandra Gică, Nicolae Ciobanu, Anca Marina Scutelnicu, Ana Maria Popescu, Mihaela Roxana Panaitescu, Anca Maria Healthcare (Basel) Review The placenta is the site of connection between maternal and fetal circulation, and the liaison is established early in pregnancy. A large variety of pregnancy complications such as preterm birth, fetal growth restriction, or pregnancy loss have placental expression and can be accompanied in some cases of acute or chronic identifiable placental inflamatory lesions. Chronic placental inflammatory (CPI) lesions include chronic villitis of unknow etiology (CVUE), chronic intervillositis of unknown etiology, CIUE (also described as chronic histiocytic intervillositis, CHI), and chronic deciduits. Hydroxychloroquine (HCQ) has been prescribed with good results during pregnancy to prevent adverse perinatal outcomes in maternal autoimmune conditions. Its success has paved the way to its use in CPI as CIUE/CHI; however, to date, there are no prospective, informatively designed, controlled studies on its value in these setting. This review aims to explore the potential role of HCQ in CPI of unknown etiology. Ideally, properly designed, probably multicentric studies should be undertaken to fully understand HCQ’s role for prevention of adverse pregnancy outcomes after a chronic placental inflammation. MDPI 2022-01-17 /pmc/articles/PMC8775717/ /pubmed/35052331 http://dx.doi.org/10.3390/healthcare10010168 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bouariu, Alexandra Gică, Nicolae Ciobanu, Anca Marina Scutelnicu, Ana Maria Popescu, Mihaela Roxana Panaitescu, Anca Maria The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes |
title | The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes |
title_full | The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes |
title_fullStr | The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes |
title_full_unstemmed | The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes |
title_short | The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes |
title_sort | potential benefit of hydroxychloroquine in chronic placental inflammation of unknown etiology associated with adverse pregnancy outcomes |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775717/ https://www.ncbi.nlm.nih.gov/pubmed/35052331 http://dx.doi.org/10.3390/healthcare10010168 |
work_keys_str_mv | AT bouariualexandra thepotentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT gicanicolae thepotentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT ciobanuancamarina thepotentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT scutelnicuanamaria thepotentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT popescumihaelaroxana thepotentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT panaitescuancamaria thepotentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT bouariualexandra potentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT gicanicolae potentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT ciobanuancamarina potentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT scutelnicuanamaria potentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT popescumihaelaroxana potentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes AT panaitescuancamaria potentialbenefitofhydroxychloroquineinchronicplacentalinflammationofunknownetiologyassociatedwithadversepregnancyoutcomes |